Indian law firm Cyril Amarchand Mangaldas has advised global PE investor Advent International on its 24.75-billion-rupee (nearly $297 million) investment in Apollo Hospitals’ (AHE) unit Apollo HealthCo.
Apollo HealthCo was represented by Shardul Amarchand Mangaldas & Co, while AZB & Partners counselled AHE.
Following the deal, Apollo HealthCo will merge its online pharmacy business, Apollo 24/7, with pharmacy distributor Keimed.
Apollo HealthCo will have an enterprise value of 144.78 billion rupees, while Keimed is valued at 80.03 billion rupees, Reuters reported, adding that the merged entity is expected to deliver revenue worth 250 billion rupees in the next three years.
The SAM transaction team, which advised Apollo HealthCo, was led by partners Puja Sondhi and Aayush Kapoor, who were assisted by principal associate Roma Das and associates Prerna Saroha and Harjas Singh.
Partners Ashni Roy, Manita Doshi, Harman Singh Sandhu and Rohan Arora also assisted on ancillary aspects of the deal.
The AZB team that advised AHE was led by senior partner Aarthi Sivanandh and partner Bhavana Alexander.
